John Maher
Affiliations: | King's College London, London, UK |
Google:
"John Maher"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Gabizon A, Shmeeda H, Draper B, et al. (2023) Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated Liposomes. Pharmaceutics. 15 |
| Maher J. (2023) Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current Perspectives. Oncotargets and Therapy. 16: 515-532 |
| Papa S, Adami A, Metoudi M, et al. (2023) Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study. Journal For Immunotherapy of Cancer. 11 |
| Maher J, Davies DM. (2023) CAR-Based Immunotherapy of Solid Tumours-A Survey of the Emerging Targets. Cancers. 15 |
| Maher J, Davies DM. (2023) CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens. Biology. 12 |
| Larcombe-Young D, Whilding L, Davies DM, et al. (2022) Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation. Star Protocols. 3: 101414 |
| Hull CM, Maher J. (2022) 3D modelling of γδ T-cell immunotherapy. Clinical and Translational Medicine. 12: e877 |
| Parente-Pereira AC, Beatson RE, Davies DM, et al. (2022) Generation and application of TGFβ-educated human Vγ9Vδ2 T cells. Star Protocols. 3: 101319 |
| Halim L, Das KK, Larcombe-Young D, et al. (2022) Engineering of an Avidity-Optimized CD19-Specific Parallel Chimeric Antigen Receptor That Delivers Dual CD28 and 4-1BB Co-Stimulation. Frontiers in Immunology. 13: 836549 |
| Beatson RE, Parente-Pereira AC, Halim L, et al. (2021) TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer. Cell Reports. Medicine. 2: 100473 |